Bacillus anthracis S-layer protein BslA binds to extracellular matrix by interacting with laminin by Yanchun Wang et al.
RESEARCH ARTICLE Open Access
Bacillus anthracis S-layer protein BslA binds
to extracellular matrix by interacting with
laminin
Yanchun Wang1*†, Ying Wei1,2†, Shengling Yuan1, Haoxia Tao1, Jie Dong1, Zhaoshan Zhang1, Wei Tian2
and Chunjie Liu1*
Abstract
Background: The Bacillus anthracis S-layer protein, BslA, plays a crucial role in mammalian infection. BslA is required
to mediate adherence between host cells and vegetative forms of bacteria and this interaction promotes target
organs adherence and blood–brain barrier (BBB) penetration in vivo. This study attempts to identify the potential
eukaryotic ligand(s) for B. anthracis BslA protein.
Results: Biochemical approaches have indicated that the putative host cell ligand(s) for BslA is a surface protein, which
is independent of the sugar components for binding to Bs1A. A ligand screening using blot overlays, far Western blots
and mass spectrometry analyses revealed that BslA binds to mammalian laminin. ELISA based solid-phase binding
assays and surface plasmon resonance assays demonstrated that there were high affinity interactions between
BslA(260–652) and laminin. The SPR results also revealed the dissociation constants values of 3.172 × 10
−9M for the
binding of BslA(260–652) to laminin.
Conclusions: These data demonstrated that laminin is a ligand for BslA.
Keywords: Bacillus anthracis, BslA protein, Laminin, Extracellular matrix, Microbial Surface Components Recognizing
Adhesive Matrix Molecules (MSCRAMM)
Background
The key to bacterial infections of host tissues is the es-
tablishment of a stable association between the bacter-
ium and host surface structures. This process also is
essential for many bacteria for withstanding cellular
mechanical cleansing processes and to ultimately allow
invasion [1]. To initially adhere to host cells, bacteria
possess various surface associated molecules that medi-
ate adherence of the bacteria to the target. Most mi-
crobes have specific adhesins, which can bind to
specific ligands on the surface of the host cell [2].
Bacterial adhesins bind to host cell ligands via a very
specific process, and the specificity of this match deter-
mines the range of host cells susceptible to infection by
a particular strain of pathogen [3]. One major class of
bacterial adhesins consists of proteins that covalently
anchor to cell peptidoglycans. These proteins specific-
ally attach to extracellular matrix (ECM) components
and are collectively termed microbial surface component
recognizing adhesive matrix molecules (MSCRAMMs)
[3–5]. MSCRAMMs mediate the initial attachment of
bacteria to host tissue, providing a critical step to establish
infection. The interaction between MSCRAMM and ECM
includes a typical receptor–ligand interaction in which
the MSCRAMM serves as the receptor. For several
pathogenic microbes, MSCRAMMs play a very import-
ant role in their pathogenesis [3, 6, 7]. Recently, anti-
adherence strategies for the prevention and treatment
of infectious diseases have been considered as an alter-
native to antibiotics [8, 9]. An increasing number of re-
searchers are focusing on studying the MSCRAMMs
and the interaction mechanism of them and related
host ligands [6, 10–13].
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Bacillus anthracis, a Gram-positive, non-motile, rod-
shaped, spore-forming bacterium, can cause fatal an-
thrax, a zoonotic disease [14]. Similar to other bacteria,
adherence to host organs also plays a very important role
in B. anthracis infection. In order to fulfill the ultimate in-
vasion process, bacteria must adhere to some specific
tissues and avoid to be eliminated. These interactions first
occur between the exosporium (such as BclA) and host
[15]. After germination, the surface proteins of the
vegetative bacterium must perform a role in adherence
to host tissues [16]. To date, two cell-wall anchored
collagen-binding proteins (BA0871 and BA5258) have
been identified in B. anthracis, but this result has not
been verified in an appropriate animal model and direct
in vivo evidence has also not been used [17]. Agarwal
et al. reported that the surface protein α-enolase of B.
anthracis display laminin-binding activity in vitro and
may contribute to invasive potential of B. anthracis
[18]. However, no evidence has been provided that this
protein is an adhesin. Moreover, the capsule and S-layer
may baffle these cell-wall anchored proteins to approach
their ligands located on host cells [17]. In addition, B.
anthracis S-layer protein A (BslA) was recently recognized
as an adhesin, expressed under host-like conditions, which
mediated adherence of vegetative bacteria to various hu-
man tissues [19–21].
Prior studies have shown that BslA is necessary and
sufficient for adherence of the B. anthracis Ames strain
to host cells despite the presence of capsule [21]. Guinea
pigs infected with a bslA mutant strain showed minimal
end organ infection, but the animals infected with wild
strain displayed disseminated infection [21]. Moreover,
BslA-mediated adherence in human endothelial cells is
regulated by B. anthracis secreted multifunctional metal-
loprotease, InhA, through promoting BslA degradation.
Regulating BslA-mediated adherence, according to the
cell phase in the host, enhanced the opportunity to bind
to epithelial/endothelial cells and move to target organs
for widespread dissemination [22]. Although BslA was
the first-identified B. anthracis surface-associated ad-
herence that promotes target organs adherence and
blood–brain barrier (BBB) penetration in vivo, the host
molecule(s) that interacts with BslA protein has (have)
not been discovered. In addition, little is known regard-
ing this process. A better understanding of B. anthracis
adherence mediated by BslA protein at the molecular
level is warranted.
To determine the potential eukaryotic ligand(s) for B.
anthracis BslA protein, we have used various approaches
to examine the BslA-mediated interactions between re-
combinant proteins and host cells. In this study we
confirmed that BslA binds to the extracellular matrix
by interacting with the laminin, and plays a role as
MSCRAMM in B. anthracis pathogenesis.
Results
Expression, purification and characterization of
recombinant proteins
To produce soluble rBslA, the truncated protein BslA(260–
652) were expressed in E.coliBL21(DE3) and purified using
Ni Resin. The purity of the recombinant protein was con-
firmed by SDS-PAGE analysis (Fig. 1a). The purified
BslA(260–652) displayed a typical adhesin-like function.
Either the anti-BslA(260–652) serum or the BslA(260–652)
protein could inhibit B. anthracis A16R’s HeLa adherence
(Fig. 1b and c). It appears that BslA interacted directly
with ligands on the surface of target cells.
The secondary structure of BslA(260–652) was analyzed
using CD spectroscopy and the NPS@ web server. As
shown in Fig. 2, CD spectrum of BslA(260–652) shows the
minima at 210 and 222 nm, which is characteristic of
α-helical secondary structure content. This suggests a
predominance of this structure in the recombinant pro-
tein. The percentage of α-helices as predicted by K2D3
is 77.29. The amino acid sequence analysis of BslA(260–652)
using NPS@ supported the results of the CD spectrum
analysis (Table 1).
The ligand(s) of BslA is a protein
To appraise the biochemical nature of the cell surface
ligand of BslA, HeLa cells were pretreated with protein-
ase or various chemical reagents before adding purified
BslA(260–652) protein. The protein binding statuses were
tested by flow cytometry and a representative tracing
were shown in Fig. 3.
When pretreated with proteinase K or trypsin, the bind-
ing of BslA(260–652) protein was completely abolished
(Fig. 3a). But cleaved with PNGase F or modified with
sodium periodate, there were no effect on BslA(260–652)
binding (Fig. 3b). These result suggest that the putative
host surface ligand(s) of B.anthracis BslA may be a surface
protein and the target site could be located on the poly-
peptide chains.
BslA binds to extracellular matrix by interacting with
laminin
It had been identified that BslA protein is exposed on
the bacterial surface. We examined whether it could ad-
here to host extracellular matrix proteins, working as a
MSCRAMM. To explore the ligand(s) binding of BslA,
blot overlay and Far Western blotting were performed
using ECM proteins as immobilized targets. As shown in
Fig. 4a and b, the BslA(260–652) interacted well with ECM
proteins.
To identify the ligand(s) of BslA, the collagenase
digested ECM proteins were examined by SDS-PAGE
and BslA(260–652) Far-Western blotting (Fig. 4b). Four pro-
tein spots were isolated and subjected to ESI-QUAD-
TOF-MS analysis after tryptic digestion. The result
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indicated that peptides belonged to the laminin and
could be found in all four protein fragments (Fig. 4b
and Additional file 1: Table S1). A second Far Western
blot was performed using mice laminin as a target lig-
and for the purpose of identifying a direct interaction
between BslA and laminin (Fig. 4c).
To further confirm that BslA protein bound to laminin
on the cell surfaces, BslA(260–652) protein was incubated
with COS-7 cells, which had been preincubated with
anti-laminin antibodies. When measured by flow cytom-
etry, anti-laminin antibodies inhibited the adherence of
BslA(260–652) (Fig. 4d). Thus, BslA appears to function as
Fig. 2 Circulardichroism spectroscopy. The processed spectra were fitted using the computer program CDNN. The spectrum shows that BslA(260–652) is
mainly constituted of α-helices (99.9 %, 195–200 nm). The far-UV CD spectrum is presented as a mean of five scans
Fig. 1 Purification, and characterization of recombinant proteins. a Coomassie-stained SDS-PAGE of purified BslA(260–652). b Gram stain analysis of
the function of BslA(260–652) in adherence of A16R to HeLa cells. a: pretreatment of B. anthracis A16R vegetative cell with naïve rabbit sera;
b: pretreatment with anti-BslA(260–652) sera; c: pretreatment of HeLa cells with PBS; d: pretreatment with purified BslA(260–652). c Histogram of
B. anthracis colony-forming units (cfu) extracted by lysis of host cells following infections pictured in (b). Error bars indicate one SEM. P-values were
calculated using a two-tailed Student’s t-test
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a B. anthracis adhesin that interacts directly with lam-
inin on the surface of target cells.
To confirm the binding of laminin to BslA on the
B.anthracis S-layer, recombinant strain expressed BslA
was constructed. Western blot analysis indicated that the
BslA expressed well in B.anthracis AP422 strain (Fig. 5a).
Then the laminin binding was further investigated by flow
cytometry according the protocol described in methods.
As shown in Fig. 5b, the AP422 strain (orange line) and
AP422(pDG148) (blue line) strain showed a little fluores-
cence shift following incubation with laminin; however,
the AP422(pbslA) strain (yellow line) showed very prom-
inent fluorescence. This result also indicated that laminin
bound to B.anthracis by interaction with BslA protein.
BslA(260–652) binds laminin with high affinity
To further characterize this interaction between BslA(260–
652) and the laminin, solid-phase binding assays were
tested. The results showed that binding of BslA(260–652) to
laminin could be fitted to a one-binding-site hyperbola
(Fig. 6a). When increasing concentrations of the recom-
binant protein (0–1000 nM) were allowed to adhere to an
immobilized laminin (1 μg/well), a dose-dependent bind-
ing was observed. ELISA analysis of the binding of differ-
ent concentrations of laminin to immobilized BslA(260–652)
also indicated that there is a specific interaction between
BslA and laminin (Fig. 6b).
The dissociation constant of the BslA(260–652)-laminin
complex was determined using SPR (Fig. 7). The ka, kd
and KD values of BslA(260-652) binding to the laminin chip
were calculated. BslA(260-652) possessed a high affinity for
laminin(KD = 3.172 × 0
−9M, ka = 1.749 × 105 M−1s−1 and
kd = 5.547 × 10−4s−1).
Discussion
Adherence of microorganisms to host surfaces is a crit-
ical step in the initiation of infection and is often medi-
ated by surface proteins or adhesins. These processes are
commonly mediated by MSCRAMMs, which recognize
and adhere to particular host factors, such as fibronec-
tin, collagens, laminin, vitronectin and elastin [4]. There-
fore, the search for and identification of MSCRAMMs
and their ligands is considered very important in bacter-
ial pathogenesis research. Kern et al observed that BslA
truncations lacking amino acids 1–260 can bind directly
to fibroblasts BJ-1 and play a key role in bacterial ad-
herence [19], but they did not identify the ligand(s) of
this important protein. In this study, using BslA(260–652)
as a research tool, we determined that BslA appears to
be a characteristic MSCRAMM that interacts with host
laminin.
BslA protein is necessary and sufficient for adherence
of B. anthracis to host cells and very important for an-
thrax pathogenesis [19, 21]. Mediated by BslA, vegetative
forms of B.anthracis (both nonencapsulated and encap-
sulated strains) adhere to host organs, such as liver,
kidney and spleen, and permit invasion [19, 21]. The
Table 1 The consensus secondary structure prediction of
BslA(260-652) using the NPS@ server
a
Prediction method
DSC GOR3 PHD SOPM Sec.Cons.
Alpha helix 84.48 % 87.79 % 82.95 % 82.44 % 82.95 %
Beta bridge 0 0 0 0 0
Beta turn 0 0 0 4.83 0
Random coil 13.99 % 8.91 % 15.52 % 10.94 % 14.5 %
aFive individual structure prediction algorithms were selected from this
analysis, and the consensus prediction is listed on the bottom line
Fig. 3 The BslA ligand is a protein; its sugar components are not involved in binding. HeLa cells were treated biochemically (see Methods) and
used for binding studies. Quantification of cell surface-bound BslA(260–652) protein on HeLa cells by flow cytometry. The percentage of mean
fluorescence in relation to untreated control cells is shown. a Cells treated with protease; b cells treated with PNGase F or sodium periodate.
Cells without BslA(260–652) protein incubated were used as negative controls
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interactions between bacterial adhesins and laminin of
host target cells play a key role in several other bacterial
pathogens such as that of meningitis [23, 24]. The major
role of epithelial laminin is to anchor cells to the basal
membrane. Bacterial penetration into the cerebrospinal
fluid requires the passage of bacteria through basement
membranes, and the interaction of bacterial surface pro-
teins with laminin could be important in this context
[25]. BslA-mediated attachment may also contribute to
the ability of B. anthracis to disrupt the BBB, a key step
in anthrax meningitis pathogenesis [20]. We speculate
that the interaction between BslA and laminin is a pos-
sible reason for BslA protein being very important in an-
thrax meningitis.
Ebrahimi et al observed that BslA contributed to BBB
degradation by disrupting the endothelial tight junctional
protein zonulaoccludens (ZO)-1 [20]. As an adhesin, BslA
has no protease activity and cannot degrade ZO-1 directly
suggesting that other proteases may cause proteolysis. It
has been established that B.anthracis-secreted metallopro-
tease InhA disrupts the BBB through proteolytic attack on
ZO-1 [26]. InhA also regulates BslA levels at a post-
translational level through direct degradation of this pro-
tein. InhA serves as a negative regulator of adherence and
invasion of B. anthracis as a result of this function [22]. At
the same time, Nrp599, another secreted neutral metallo-
protease of B. anthracis, also directly digests host laminin
[27]. Therefore, we speculate that the interaction between
BslA and laminin was strongly regulated by bacteria. It
may be very important to the dissemination of B. anthra-
cis during infection occurrence.
For several pathogenic Gram-positive bacteria, laminin
is an important ligand molecule of MCSRAMMs [28–31].
Our study also focused on it and identified a corroborative
interaction between BslA and laminin. The possibility that
there are other ECM molecules interacting with BslA still
Fig. 4 Identification of the interaction between BslA and laminin. a Dot Blot (1, 2, 3, ECM incubated with BslA(260–652), triplicate dot; 4,5, 6, ECM
incubated with sonicated E. coli BL21(DE3) triplicate dot). The result of the overlay suggested that the ligand(s) of BslA are located in the ECM
component. b Far Western blot. Both non- pretreated ECM (lane 1 and lane 4) and collagenase-digested ECM (lane 2, 3, 5) were used for Far
Western blot test. The proteins indicated by arrows were analyzed by MS. c Far Western blot using laminin as target protein. Lane 1, both BslA(260-652)
and polyclonal BslA antibody was added regularly. Lane 2, only the polyclonal BslA serum was added, negative control. d Flow cytometry analysis of
the blocking effect of anti-laminin polyclonal antibodies. Cells were preincubated with laminin-specific antibodies (1:50 dilution) or naive rabbit sera for
1 h prior to incubation with BslA(260–652)
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needs to be explored as the next step. There are number
of bacterial adherence molecules with more than one host
molecule ligand interactions [32].
Conclusions
In conclusion, we report here a novel potential ligand (lam-
inin) for BslA, which may help elucidate the important
molecular mechanisms involved in the adherence of
B.anthracis to host organs.
Methods
Bacterial strains, culture cells and culture conditions
All bacterial strains used in the present study and their rele-
vant characteristics are listed in Additional file 2: Table S2.
All the used B. anthracis strains were derivatives of the
Fig. 5 Analysis of laminin binding to B.anthracis AP422 expressing BslA. a Western blot analysis of the expression of BslA. M, protein maker; lane 1,
AP422; lane 2, AP422(pDG148); lane 3,AP422(bslA). b Flow cytometry analysis of laminin binding to B. anthracis AP422 expressing BslA. All Bacteria
were incubated with or without laminin. Each curve represents analysis of 30,000 bacteria
Fig. 6 Analysis of the interaction between BslA(260–652) and laminin. a ELISA analysis of the binding of different concentrations of BslA(260–652) to
immobilized laminin. b ELISA analysis of the binding of different concentrations of laminin to immobilized BslA(260–652) with and without the
presence of an excess of BslA(260–652) in solution. Responses at equilibrium of the ELISA curves were fit to a one-site binding (hyperbola) isotherm
(GraphPad Prism 5). All values are the averages of repeat experiments performed in triplicate with the background absorption subtracted.
Error bars indicate SEM
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Chinese vaccine strain A16R. Bacteria were aerobically
grown at 37 °C. Escherichia coli strains were grown in
Luria–Bertani (LB) broth and used as hosts for plasmid
cloning and recombinant protein expression. B. anthracis
strains were grown in brain heart infusion medium with
0.5 % glycerol (BHIG; BD, USA) or LB media. Antibiotics
(Merck, Germany) were added to the media when appro-
priate to the following final concentrations: 100 μg/mL
ampicillin for E. coli; 50 and 25 μg/mL kanamycin (kan) for
E. coli and B. anthracis, respectively.
HeLa human cervix carcinoma or COS-7 cells were
cultured in RPMI-1640 medium supplemented with
2 mM L-glutamine and 10 % FCS in a 5 % CO2 at-
mosphere at 37 °C.
Recombinant proteins and rabbit-anti-BslA antibodies
Total chromosomal DNA from B. anthracisA16R was
used as a template to amplify bslA truncation using the
primers (BslA(260-652) F: 5′-CGGGATCCGAAGAATT
GAATCAAAAGTT-3′, BslA(260-652) R: 5′-CCGCTCGA
GACTGTTTGGTATTCTAAGTTT-3′). To obtain the
recombinant BslA(260–652) protein of B. anthracis and
prepare its antibody used for the adherence activity stud-
ies, the fragment encoding BslA(260–652) was cloned into
the pET28a(+) plasmid and induced to express recom-
binant protein in E. coli Rosetta (DE3) by IPTG. The
expressed recombinant protein was purified by a column
packed with ProBond™ Purification System (Life Tech-
nologies) according to the manufacturer’s instructions.
Purified protein was used as the antigen to immunize
rabbits three times to raise polyclonal antibodies. IgG
was purified using protein G-Sepharose (GE Healthcare)
affinity chromatography.
Circular dichroism (CD) spectroscopy
CD spectroscopy measurements were performed in a
Chirascan CD Spectrometer (UK Applied Photophysics).
The purified recombinant protein was dialyzed using
10 mM sodium phosphate buffer at a concentration of
0.2 mg/ml. Far-UV (196–260 nm) spectra were acquired
using a 1-mm-path-length cell at 0.5 nm intervals. Five
scans were accumulated and the mean value determined.
For the analysis of the secondary structure, these data
were analyzed using the online servers K2D3 [33]. Con-
currently, the secondary structure prediction also was
executed using the Network Protein Sequence Analysis
(NPS@site at https://npsa-prabi.ibcp.fr/cgi-bin/npsa_au-
tomat.pl?page=/NPSA/npsa_seccons.html) [34].
BslA(260–652) adherence bioactive assays
Replenished B. anthracis A16R cultures, grown to an
OD600 of 0.5, were inoculated into 12-well tissue culture
plates containing monolayers of HeLa cells. Infected
monolayers were centrifuged at 600 × g for 5 min to
synchronize infection, and then incubated at 37 °C in
5 % CO2, 100 % humidity for 4 h. Cells were washed five
times with PBS. Standard Gram staining was performed
and bacteria were removed from the wells by adding
100 μl of 0.25 % trypsin. Serial dilutions were plated in
triplicate on LB agar and grown at 37 °C overnight.
For BslA-specific antiserum inhibition experiments,
cultures of B. anthracis were preincubated with 2 %
BslA-specific or naive rabbit sera for 1 h at 4 °C prior to
infection. For protein inhibition experiments, cells were
preincubated with purified BslA(260–652) protein (25 μg
of protein/1 × 106 cells) for 1 h at 37 °C in FCS free
medium and washed twice before infection.
Fig. 7 Surface plasmon resonance analysis of BslA(260–652) binding to laminin. Two-fold linear dilution series of BslA(260–652) (4.938, 9.875, 19.75,
39.5 and 79 nM) were injected over the laminin surface (2000 response units) on a BIAcore sensor chip using single-cycle kinetics. Red line con-
trasts the measured data from the simulated fits (black line). Data are representative of two independent experiments
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Biochemical treatment of cells
HeLa cells were grown to 80–90 % confluency and
washed with PBS, then detached from the plate with
0.04 % EDTA (10 mM in PBS). Cells were washed and
resuspended in approximately 1 × 107 cells/ml in ice cold
PBS. For protease treatment, the cells were incubated
with 40 μg/ml trypsin or 6 μg/ml proteinase K for
30 min at 4 °C. To degrade the carbohydrate structures
on cell surfaces, the cells were incubated with peptide-
N-glycosidase F (PNGase F) for 1 h at 4 °C or incubated
with 30 mM sodium periodate in 50 mM sodium acetate
buffer (pH 4.5) for 1 h at room temperature in the dark.
After washing three times with PBS and blocking with
3 % FCS in medium, cells were used for flow cytometry
analysis experiments as described further.
Flow cytometry analysis
BslA(260–652) protein was added to the pretreated cells
(25 μg of protein/1 × 106 cells) and incubated for 1 h at
4 °C. Cells were washed three times with PBS, and sus-
pended in PBS containing 3 % FCS and BslA(260–652)-
specific antiserum (1:100, v/v) and incubated on ice for
1.5 h. After washing 3X with PBS, the cells were incubated
with FITC-conjugated goat anti-rabbit IgG (1:1000, v/v;
Abcam) on ice for 1 h. Then the cells were stained with
0.5 mg/ml of 7-AAD (KeyGen Biotech) for 10 min and
the FITC-labeled cells (7-AAD negative, live) were exam-
ined with FACSCalibur (BD Biosciences, USA).
Blot overlay/Far western blotting assay
For blot overlays, the commercial extracellular matrix
(ECM, Corning Life Sciences) were blotted onto nitrocel-
lulose membranes and air dried. For the far Western blot,
ECM proteins (collagenase-digested or non-pretreated)
were separated on 4–12 % SDS-PAGE and transferred to
nitrocellulose membranes. All the membranes were
blocked in 5 % fat-free milk in PBST for 1 h. Following
several washes with PBST, BslA(260–652) protein in
PBST/milk (1 μg/ml) was added to the nitrocellulose
membranes, incubated for 1 h at 37 °C, and washed sev-
eral times. Detection was performed using BslA(260–652)-
specific antiserum and HRP-conjugated goat anti-rabbit
IgG. For blot overlay test, the sonicated E. coli BL21(DE3)
was used as negative control.
Mass spectrometry analysis
Further identification of the ligand of BslA was con-
ducted using a combination of the Far Western blotting
studies and mass spectrometry (MS). To separate the
proteins well and fit mass spectrometry analysis, the
ECM protein were digested by collagenase and separated
on 4–12 % SDS-PAGE. Separated proteins were electro-
transferred to nitrocellulose membranes or stained with
Coomassie Blue. The far western blotting was used to
determine signals of corresponding protein spots located
on the colloidal coomassie gel.
Polypeptides cut out from the coomassie gel were ana-
lyzed by ESI-QUAD-TOF. The proteins were identified
against the NCBI database using the MASCOT program
(www.matrixscience.com), where protein scoring of >82
was significant (p < 0.05).
Blocking assays
For ligand antiserum inhibition experiments, COS-7 cells
were preincubated with laminin-specific polyclonal anti-
bodies (Merck Millipore, 1:50 dilution) or naive rabbit sera
for 1 h prior to incubation with BslA(260–652) at 4 °C.
After washing three times with PBS and blocking with
3 % FCS in medium, cells were labeled with BslA(260–652),
followed by mice anti-His tag antibodies and FITC-
conjugated rabbit anti-mice IgG for flow cytometry ana-
lysis experiments.
Solid-phase binding assays
To determine binding of BslA(260–652) to immobilized
laminin, wells of Costar 96-well plates (Corning) were
coated overnight with 20 μg/ml EHS laminin in 50 mM
Na2CO3 (pH 9.6) at 4 °C. Plates washed three times with
PBS plus 0.5 % Tween-20 (PBST). Wells were blocked
for 2 h at 37 °C with Superblock (Thermo Fisher), and
then washed three times with PBST. Wells were incubated
for 2 h at 37 °C with 100 μl of various concentrations of
recombinant BslA(260–652) in PBST (plus 0.1 % BSA) and
developed with BslA(260–652)-specific rabbit polyclonal
antiserum, followed by goat-anti rabbit HRP-IgG. Plates
were washed three times with PBST, incubated for 1 h at
37 °C with HRP-conjugated goat anti-rabbit IgG (Jackson),
and diluted 1:5000 in PBST-2 % fat-free milk. After wash-
ing, 100 μl of TMB substrate solution (TianGen) was
added to the wells in the microtiter plate. After 10 min at
room temperature, the reaction was interrupted by adding
50 μl of 1 M H2SO4. Absorbance was read at 450 nm in a
Spectra Max 190 ELISA microplate reader (Molecular De-
vices). A binding curve was generated using Graphpad
Prism, version 5.
To determine the binding of laminin to immobilized
BslA(260–652), recombinant BslA(260–652) was diluted in
carbonate buffer, pH 9.6, to 1 μg/ml, and 50 μl/well was
coated on Costar 96-well plates (Corning) overnight.
The wells were washed, blocked, probed with 100 μl of
soluble EHS laminin (0–100 mg/ml), and developed with
rabbit anti-mouse laminin antibody (Merck Millipore),
followed by goat-anti rabbit HRP-IgG.
Surface Plasmon Resonance (SPR)
All surface plasmon resonance (SPR) experiments were
performed using a Biacore T200 instrument at 25 °C
(GE Healthcare) using the single-cycle kinetics (SCK)
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experiments. Briefly, The CM-5 chip was activated with
a 1:1 mixture of 0.4 M 1-ethyl-3-(3-dimethylaminopro-
pyl) carbodiimide and 0.1 M N-hydroxysuccinimide for
7 min. Laminin (10 μg/mL in 10 mM sodium acetate
buffer, pH 4.0) was immobilized on the surface of individual
CM5 chips a flow rate of 5 ml/min. Approximately 2000RU
of laminin were immobilized. After immobilization, CM5
chips were inactivated with 1 M ethanolamine-HCl.
Increasing concentrations of BslA(260–652) in HBS-EP
+
buffer(10 mM HEPES,150 mM NaCl,3 mM EDTA,0.05 %
P20,pH 7.4) were injected at 30 μl/min over both the ligand
and reference surfaces for 3 min then allowed them to dis-
sociate for 15 min at 25 °C. Data processing and analysis
were performed using BiacoreT200 evaluation software in a
1:1 binding model (GE Healthcare).
B.anthracis AP422 Expressing BslA
PCR reactions were performed with Pfu DNA polymerase
(Transgene) using the primers (BslAF: 5′-GAAGCTT
AAGGAGGAAGCAGGTATGAAAAAAAGAAAGATAA
AAG-3′, BslAR: 5′-CATGCATGCTTAACTGTTTGGTA
TTCT-3′). The fragment coding BslA was cloned into the
shuttle vector pDG148and the ligation products were
transformed into E. coli DH5α, and plasmid DNA into E.
coli SCS100 (dam-, dcm-) and purified (nonmethylated)
plasmid DNA was transformed into B. anthracis following
a previously developed protocol [35].
Bacterial adherence laminin assays
Replenished B. anthracis AP422, AP422(pDG148) and
AP422(bslA) cells, induced to express BslA protein by
IPTG 4 h before harvest, were washed and resuspended
in filtered PBS supplemented with 2 % BSA. Laminin
(2 μl of a 1 mg/ml solution) was added to microtubes
(1.5 ml), and incubated at 37 °C in the dark for 1 h. Fol-
lowing three washes with PBST, bacteria were incubated
for 2 h at 37 °C with a 1:100-diluted rabbit anti-mouse
laminin antibody in PBS containing 2 % BSA and incu-
bated on ice for 1.5 h. After washing three times with
PBS, the cells were incubated with Alexa Fluor 488 -la-
beled goat anti-rabbit IgG (1:100, v/v) (Life Technologies)
on ice for 1 h. The Alexa Fluor 488-labeled cells were ex-
amined using FACSCalibur (BD Biosciences). Unlabeled
bacteria AP422 were used as negative controls.
Statistical methods
All the statistical analyses were performed with the
GraphPad Prism 5 software. Data are presented as mean
value with the standard deviation (±1 S.D.). Statistical
significance was tested using Student’s paired t-test or
One-way ANOVA. Differences were considered significant
at p < 0.05. The correlation coefficient (R) and p-value
(two-tailed) were calculated at 95 % confidence interval.
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